Titelia

Holdings of DIADEMA PARTNERS LP

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
75 in 4 countries
Top ten
51.7 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Viking Therapeutics Inc 525,18117.1M $
2United Therapeutics Corp 27,30316.2M $
3Johnson & Johnson 53,77113.1M $
4COGENT BIOSCIENCES INC 322,76412.4M $
5Terns Pharmaceuticals Inc 181,7529.6M $
6BioMarin Pharmaceutical Inc 148,2298.4M $
7ABIVAX SA 75,9448.2M $
8REVOLUTION MEDICINES INC 80,8727.9M $
9Kodiak Sciences Inc 192,9627.4M $
10Incyte Corp 78,0297.3M $
11TG THERAPEUTICS INC 206,9286.9M $
12Bridgebio Pharma Inc 85,3116.3M $
13Immunocore Holdings PLC 193,1895.8M $
14Eli Lilly & Co 6,0005.5M $
15AbbVie Inc 24,0585.2M $
16ARCUS BIOSCIENCES INC 238,1425.1M $
17Corbus Pharmaceuticals Holdings Inc 439,9574.1M $
18Corvus Pharmaceuticals Inc 244,8113.6M $
19Zymeworks Inc 142,1323.6M $
20STRUCTURE THERAPEUTICS INC 72,2343.5M $
21Monte Rosa Therapeutics Inc 187,3073.1M $
22Tenax Therapeutics Inc 179,7382.9M $
23Harmony Biosciences Holdings Inc 92,8642.6M $
24Capricor Therapeutics Inc 78,8512.4M $
25EyePoint Inc 178,5452.3M $
26BICYCLE THERAPEUTICS PLC 476,4242.2M $
27Indivior Pharmaceuticals Inc 71,3762.2M $
28Climb Bio Inc 286,1262M $
29INVENTIVA SA 352,3991.9M $
30Shattuck Labs Inc 293,6641.9M $
31TARSUS PHARMACEUTICALS INC 25,9421.8M $
32MacroGenics Inc 600,0001.7M $
33Vertex Pharmaceuticals Inc 3,8401.7M $
34Voyager Therapeutics Inc 423,6421.6M $
35VAXCYTE INC 25,0711.5M $
36Relmada Therapeutics Inc 200,8421.4M $
37BioAge Labs Inc 60,0001M $
38INOVIO PHARMACEUTICALS INC 562,665979K $
39Aytu BioPharma Inc 353,077963.9K $
40Equillium Inc 433,844867.7K $
41Dianthus Therapeutics Inc 10,000839.2K $
42Enanta Pharmaceuticals Inc 64,952820.3K $
43Replimune Group Inc 100,660770K $
44Xeris Biopharma Holdings Inc 132,746769.9K $
45Larimar Therapeutics Inc 166,637749.9K $
46Annexon Inc 132,916736.4K $
47Ultragenyx Pharmaceutical Inc 35,144736.3K $
48Mineralys Therapeutics Inc 26,347713.7K $
49Unicycive Therapeutics Inc 106,083698K $
50Spruce Biosciences Inc 10,000653.5K $
51Phathom Pharmaceuticals Inc 54,650607.2K $
52Celcuity Inc 5,314606.5K $
53Novo Nordisk A/S 14,577520.7K $
54Pelthos Therapeutics Inc 24,773520.5K $
55MannKind Corp 186,603457.2K $
56Maze Therapeutics Inc 15,000447.8K $
57Corcept Therapeutics Inc 10,000403.1K $
58Lipocine Inc 50,000399.5K $
59Foghorn Therapeutics Inc 79,944382.1K $
60Ocugen Inc 200,000362K $
61PepGen Inc 150,925267.1K $
62Trevi Therapeutics Inc 21,663258.4K $
63Precigen Inc 55,293214K $
64Upstream Bio Inc 21,609194.5K $
65COMPASS PATHWAYS PLC 31,885176.3K $
66Passage Bio Inc 19,530153.3K $
67TALPHERA INC 153,563114.7K $
68Rocket Pharmaceuticals Inc 30,579109.5K $
69Monopar Therapeutics Inc 1,63089.3K $
70VISTAGEN THERAPEUTICS INC 105,42860.3K $
71Atrium Therapeutics Inc 2,51233.6K $
72CUE BIOPHARMA INC 131,99730.3K $
73PURETECH HEALTH PLC 7,92411.3K $
74Enliven Therapeutics Inc 2459.6K $
75Septerna Inc 2024.9K $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Health care 23.9 %
  • Unattributed 76.1 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 93.7 %
  • France 4.9 %
  • United Kingdom 1.2 %
  • Denmark 0.3 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States69195.2M $93.72 %
2France210.2M $4.88 %
3United Kingdom32.4M $1.15 %
4Denmark1520.7K $0.25 %
Cite this page

Titelia. "Holdings of DIADEMA PARTNERS LP". https://titelia.com/en/funds/US13F2026172